In 2024, Maher Masoud earned $990.00K in total compensation at MaxCyte, including $590.00K salary and $389.40K bonus. Most recently acquired 100,000 shares in Jun 2024. Currently holds stock worth $257.25K. 1+ years at the helm of MaxCyte.
Compensation History
Annual executive compensation data for Maher Masoud, including salary, bonuses, and stock awards.
Year
2024
Total Compensation
$990.00K
Salary
$590.00K
Bonus
$389.40K
Other
$10.60K
Salary
$590.00KBoard Justification
Our Compensation Committee considers compensation for comparable positions in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders and a long-term commitment to our company.
Bonus
$389.40KBoard Justification
Each of our executive officers is eligible to receive performance bonus under our annual incentive compensation program. Under our 2024 annual incentive compensation program, each of our NEOs was eligible to receive a cash incentive payment equal to (1) his target incentive, as a percentage of annual base salary, multiplied by (2) the percentage achievement of certain 2024 corporate goals established by our Compensation Committee in its sole discretion, and approved by our Board, subject to the NEO remaining employed by us through the payment date. Mr. Masoud’s target incentive was set at 60% of his annual base salary. The corporate goals used for purposes of the 2024 annual incentive compensation program included revenue, EBITDA, and targets related to product development, manufacturing and engineering, corporate development, employee retention, and partnership licensing. Our Compensation Committee determined that the percentage achievement of the applicable corporate goals was 110% for each of the NEOs.
Other Compensation
$10.60KBoard Justification
For 2024, consists of matching contributions under our 401(k) plan paid by us during 2024 and, for 2024, tax reimbursements received by each NEO relating to a Company-wide gift program available to all Company employees that the NEOs participated in through the first quarter of 2024.
Restricted Stock
Board Justification
N/A
Performance Metrics
The corporate goals used for purposes of the 2024 annual incentive compensation program included revenue, EBITDA, and targets related to product development, manufacturing and engineering, corporate development, employee retention, and partnership licensing.
Maher Masoud
CEO of MaxCyte
Education
JD from Harvard Law School, BA from University of California, Berkeley.
Field of Expertise
Legal & Compliance - Law
Sector of Economy
Healthcare
Born
January 1, 1978 - 47 years ago
CEO of MaxCyte for
1 year 11 months (Jan 2024 - Present)
Previous Experience
Executive Vice President, General Counsel and Secretary at MaxCyte, Inc.
Other MaxCyte CEOs
Holdings
Track Maher Masoud's stock holdings and portfolio value over time.
Total Stock Sold
$933.03K
$933.03K
75,000 MXCT shares
What if they kept their stock?
If Maher Masoud didn't sell their stock, today they would have:
Extra MXCT75,000 shares worth $110.25K.
This is -88.18% and $822.78K less than what they got when they sold the stock.
Insider Trading
Maher Masoud's recent stock transactions, purchases, and sales filed with the SEC.
$488.35K
MXCT at $4.88/share
Jun 7, 2024
Purchase
$922.50K
MXCT at $12.30/share
Nov 12, 2021
Sale
Rivals
Compare Maher Masoud with competitor CEOs and industry peers.